New Drug Applications Archive
Get news By email or subscribe to our News feeds.
October 2008
October 1
October 15
October 17
October 20
FDA Adds Three Months to Review of Takeda's New Drug Application for TAK-390MR
AMAG Pharmaceuticals Receives Complete Response Letter from FDA for Ferumoxytol
Discovery Labs Submits Complete Response to May 2008 FDA Approvable Letter for Surfaxin for RDS
NexMed Discusses End of Review Meeting for Vitaros
FDA Defers Final Action on Milnacipran New Drug Application
October 21
October 27
October 29
October 31
Spectrum Pharmaceuticals Files Supplemental New Drug Application with FDA for Fusilev in Colorectal Cancer
Erbitux Supplemental Biologics License Application for First-Line Recurrent or Metastatic Head and Neck Cancer Accepted for Priority Review by U.S. Food and Drug Administration
Savient Submits Biologics License Application (BLA) for Pegloticase
